Daniel Lundell

4.4k total citations
57 papers, 3.4k citations indexed

About

Daniel Lundell is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Daniel Lundell has authored 57 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 24 papers in Immunology and 20 papers in Molecular Biology. Recurrent topics in Daniel Lundell's work include Chemokine receptors and signaling (14 papers), Immune Response and Inflammation (12 papers) and Immunotherapy and Immune Responses (9 papers). Daniel Lundell is often cited by papers focused on Chemokine receptors and signaling (14 papers), Immune Response and Inflammation (12 papers) and Immunotherapy and Immune Responses (9 papers). Daniel Lundell collaborates with scholars based in United States, United Kingdom and Germany. Daniel Lundell's co-authors include Satwant K. Narula, Charles A. Lunn, Xuedong Fan, Waldemar Gonsiorek, R. William Hipkin, James Fossetta, Jay S. Fine, Joseph A. Kozlowski, Alexander N. Glazer and William T. Windsor and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Daniel Lundell

57 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Lundell United States 27 1.3k 977 923 538 527 57 3.4k
Satwant K. Narula United States 35 1.1k 0.8× 2.9k 3.0× 1.4k 1.5× 698 1.3× 483 0.9× 67 5.3k
Ronald L. Magolda United States 29 3.0k 2.3× 728 0.7× 950 1.0× 493 0.9× 635 1.2× 69 5.6k
Takashi Izumi Japan 39 2.4k 1.9× 690 0.7× 427 0.5× 783 1.5× 299 0.6× 150 4.7k
Lih‐Ling Lin United States 29 3.8k 2.9× 1.3k 1.4× 743 0.8× 756 1.4× 512 1.0× 50 6.0k
James D. Clark United States 34 3.2k 2.4× 1.3k 1.3× 817 0.9× 979 1.8× 610 1.2× 77 6.3k
Alan H. Drummond United Kingdom 30 2.0k 1.6× 769 0.8× 824 0.9× 371 0.7× 189 0.4× 70 4.4k
Dennis E. Van Epps United States 29 1.2k 0.9× 843 0.9× 307 0.3× 339 0.6× 361 0.7× 95 3.1k
Djordje Miljković Serbia 33 1.1k 0.9× 1.3k 1.4× 651 0.7× 320 0.6× 188 0.4× 159 4.0k
Mark E. Goldman United States 39 2.3k 1.7× 919 0.9× 847 0.9× 332 0.6× 259 0.5× 103 6.0k
Dean E. McNulty United States 24 3.8k 2.9× 1.2k 1.2× 1.4k 1.5× 342 0.6× 227 0.4× 35 5.8k

Countries citing papers authored by Daniel Lundell

Since Specialization
Citations

This map shows the geographic impact of Daniel Lundell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Lundell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Lundell more than expected).

Fields of papers citing papers by Daniel Lundell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Lundell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Lundell. The network helps show where Daniel Lundell may publish in the future.

Co-authorship network of co-authors of Daniel Lundell

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Lundell. A scholar is included among the top collaborators of Daniel Lundell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Lundell. Daniel Lundell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tong, Ling, Seong Heon Kim, Lei Chen, et al.. (2017). Development of a prodrug of hydantoin based TACE inhibitor. Bioorganic & Medicinal Chemistry Letters. 27(16). 3704–3708. 5 indexed citations
2.
Jenh, Chung‐Her, Mary Ann Cox, Long Cui, et al.. (2012). A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection. BMC Immunology. 13(1). 2–2. 74 indexed citations
3.
Huang, Xianhai, Xiaohong Zhu, Xiaohong Chen, et al.. (2011). A three-step protocol for lead optimization: Quick identification of key conformational features and functional groups in the SAR studies of non-ATP competitive MK2 (MAPKAPK2) inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(1). 65–70. 18 indexed citations
4.
Tong, Ling, Lei Chen, Razia Rizvi, et al.. (2010). Expansion of SAR studies on triaryl bis sulfone cannabinoid CB2 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 20(22). 6785–6789. 19 indexed citations
5.
Min, Soo, Yuanfan Wang, Waldemar Gonsiorek, et al.. (2009). Pharmacological targeting reveals distinct roles for CXCR2/CXCR1 and CCR2 in a mouse model of arthritis. Biochemical and Biophysical Research Communications. 391(1). 1080–1086. 52 indexed citations
6.
Taveras, Arthur G., Younong Yu, Junying Zheng, et al.. (2009). 3,4-Diamino-1,2,5-thiadiazole as potent and selective CXCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 19(5). 1434–1437. 8 indexed citations
7.
Taveras, Arthur G., Michael P. Dwyer, Younong Yu, et al.. (2009). Fluoroalkyl α side chain containing 3,4-diamino-cyclobutenediones as potent and orally bioavailable CXCR2–CXCR1 dual antagonists. Bioorganic & Medicinal Chemistry Letters. 19(5). 1431–1433. 13 indexed citations
8.
Gall, Sylvain M. Le, Pierre Bobé, Karina Reiß, et al.. (2009). ADAMs 10 and 17 Represent Differentially Regulated Components of a General Shedding Machinery for Membrane Proteins Such as Transforming Growth Factor α, L-Selectin, and Tumor Necrosis Factor α. Molecular Biology of the Cell. 20(6). 1785–1794. 214 indexed citations
9.
Mazzola, Robert, Zhaoning Zhu, Brian A. McKittrick, et al.. (2008). Discovery of novel hydroxamates as highly potent tumor necrosis factor-α converting enzyme inhibitors. Part II: Optimization of the S3′ pocket. Bioorganic & Medicinal Chemistry Letters. 18(21). 5809–5814. 28 indexed citations
10.
Gonsiorek, Waldemar, David Hesk, Shu‐Cheng Chen, et al.. (2006). Characterization of Peripheral Human Cannabinoid Receptor (hCB2) Expression and Pharmacology Using a Novel Radioligand, [35S]Sch225336. Journal of Biological Chemistry. 281(38). 28143–28151. 20 indexed citations
11.
Niu, Xiaoda, Shelby P. Umland, Richard Ingram, et al.. (2006). IK682, a tight binding inhibitor of TACE. Archives of Biochemistry and Biophysics. 451(1). 43–50. 46 indexed citations
12.
Lunn, Charles A., Jay S. Fine, Alberto Rojas-Triana, et al.. (2006). A Novel Cannabinoid Peripheral Cannabinoid Receptor-Selective Inverse Agonist Blocks Leukocyte Recruitment in Vivo. Journal of Pharmacology and Experimental Therapeutics. 316(2). 780–788. 112 indexed citations
13.
Fan, Xuedong, Andriani C. Patera, Gregory Deno, et al.. (2006). Murine CXCR1 Is a Functional Receptor for GCP-2/CXCL6 and Interleukin-8/CXCL8. Journal of Biological Chemistry. 282(16). 11658–11666. 171 indexed citations
14.
Cox, Mary Ann, Maria Wiekowski, B. Wilburn, et al.. (2005). The pyrimidinergic P2Y6 receptor mediates a novel release of proinflammatory cytokines and chemokines in monocytic cells stimulated with UDP. Biochemical and Biophysical Research Communications. 330(2). 467–473. 49 indexed citations
15.
Fine, Jay S., Alberto Rojas-Triana, James V. Jackson, et al.. (2003). Impairment of Leukocyte Trafficking in a Murine Pleuritis Model by IL-4 and IL-10. Inflammation. 27(4). 161–174. 20 indexed citations
16.
Fossetta, James, James Jackson, Gregory Deno, et al.. (2003). Pharmacological Analysis of Calcium Responses Mediated by the Human A3 Adenosine Receptor in Monocyte-Derived Dendritic Cells and Recombinant Cells. Molecular Pharmacology. 63(2). 342–350. 51 indexed citations
17.
Shan, Li-Xin, Xudong Qiao, Elizabeth R. Oldham, et al.. (2000). Identification of Viral Macrophage Inflammatory Protein (vMIP)-II as a Ligand for GPR5/XCR1. Biochemical and Biophysical Research Communications. 268(3). 938–941. 28 indexed citations
18.
Walter, Mark R., William T. Windsor, Tattanahalli L. Nagabhushan, et al.. (1995). Crystal structure of a complex between interferon-γ and its soluble high-affinity receptor. Nature. 376(6537). 230–235. 303 indexed citations
19.
Lundell, Daniel, Charles A. Lunn, David C. Dalgarno, et al.. (1991). The carboxyl-terminal region of human interferon γ is important for biological activity: mutagenic and NMR analysis. Protein Engineering Design and Selection. 4(3). 335–341. 64 indexed citations
20.
Lundell, Daniel, Robert S. Greenberg, James Fossetta, et al.. (1990). Cytoplasmic and periplasmic expression of a highly basic protein, human interleukin 4, inEscherichia coli. Journal of Industrial Microbiology & Biotechnology. 5(4). 215–227. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026